Dec21
Royal Philips Electronics does buyout of Respironics for $5.1 billion
Respironics, Inc. has announced it’s entered into a merger agreement which will allow Royal Philips Electronics (Philips) to acquire all of the outstanding shares of Respironics for USD 66.00 in cash per share, or a total purchase price of approximately $5.1 billion. The offer price represents a premium of approximately 31 percent over Respironics’ average closing share price for a period of 30 trading days ending at market closing on December 20, 2007.
The Board of Directors of Respironics has unanimously approved the transaction and recommends that Respironics shareholders accept and tender their shares into the offer. The tender offer is expected to commence by January 8, 2008, and is subject to customary conditions, including the tender of at least a majority of the shares and the receipt of U.S. and European regulatory approvals. The offer is not subject to any financing contingency, and the transaction is expected to be completed in the first quarter of 2008.
Upon completion of this acquisition, Respironics will become the centerpiece of Home Healthcare Solutions, which will form part of Philips Healthcare as of January 1, 2008.
Respironics is an international leader in the products to treat of obstructive sleep apnea (OSA), a sleep disorder characterized by the repeated cessation of breathing during sleep.
In the United States alone, it’s estimated there are between 18 and 20 million people who have moderate or severe sleep apnea, yet it’s estimated that less than 20 percent of those people have been diagnosed. Over the past decade, research has demonstrated links between sleep apnea and sexual dysfunction, heart disease, stroke, and diabetes, among other issues, such increased risk of involvement in motor vehicle accidents, among other issues.
Respironics has a leading position in non-invasive ventilation and has recently introduced new home oxygen technologies to serve the needs of respiratory impaired patients in the home. The remainder of the company’s business is focused on the hospital channel, which includes non-invasive and invasive ventilation, respiratory monitoring, neonatal products, and respiratory drug delivery technologies for the treatment of respiratory diseases.
Upon completion of the merger, Respironics will become Philips Home Healthcare Solutions’ headquarters within Philips Healthcare. It’s expected that Respironics’ senior operating leadership will remain with the organization, continuing to lead and manage the business.
Over the years, Philips has made a number other home health related acquisitions, including Lifeline Systems, Health Watch and Raytel Cardiac Services. Combined, the business unit supports almost one million at-risk seniors, either in their own homes or in senior living facilities throughout the U.S. and Canada.
Respironics is a leading developer, manufacturer, marketing its products in 141 countries, and has employs more than 5,300 associates worldwide.
Royal Philips Electronics, based in the Netherlands, is a leader in healthcare, lighting and consumer lifestyle, delivering products, services and solutions through the brand promise of “sense and simplicity.” The company have more approximately 128,000 employees in more than 60 countries. In 2006, it took in €27 billion in sales.
In announcing the buyout, John L. Miclot, president and chief executive officer of Respironics, said, “The transaction will deliver superior and certain value to Respironics’ shareholders. The combination of Respironics and Philips will allow us to continue to provide exceptional products and services to our customers and allow Respironics to expand its leadership in the global sleep and respiratory markets.”
Continuing, Miclot said, “Philips is the right partner to create additional growth opportunities for our company, and we believe that our organization will benefit significantly by being part of a larger, growing and dynamic organization. We look forward to working with the Philips team to ensure an effective and seamless transition.”
“A core part of Philips’ healthcare strategy is to achieve a leading position in the high growth sector of home healthcare,” Steve Rusckowski, Philips Healthcare chief executive officer and member of the Philips Electronics Board of Management, said, “This acquisition, with its significant strategic and financial benefits to Philips Healthcare, is another important step in carrying out this strategy.”
Related Links |
Technorati Tags: Respironics, Philips, Royal Philips Electronics, the Netherlands, Philips Home Healthcare Solutions, Steve Rusckowski, John L. Miclot, merger, sleep markets, sleep, sleep disorders, sleep apnea, respiratory markets, Lifeline Systems, Health Watch, Raytel Cardiac Services, United States, Canada, invasive ventilation, non-invasive ventilation, heart disease, stroke, diabetes, sexual dysfunction, research, acquisition, buyout, cessation, breathing, snoring, oxygen, respiratory
If you enjoyed this post, make sure you subscribe to my RSS feed!
No Comments »Uncategorized

